Russia is already testing the first samples of Sputnik V that were produced in India, its embassy in New Delhi said on Twitter on Friday, sharing a news story in which their vaccine czar Kirill Dmitriev was quoted. "India will produce about 300 million doses or more of the vaccine for us next year." India is the world's biggest vaccine maker and its pharmaceutical industry is freeing up capacity and accelerating investments ahead of the global rush for Covid-19 shots. India's Hetero Biopharma has already announced a deal with the RDIF to make more than 100 million doses of Sputnik V, whose efficacy has been found to be more than 91% in trials done outside India. So far only three vaccines from Oxford-AstraZeneca, Pfizer /BioNTech and Indian company Bharat Biotech have applied for urgent approval.

Source: Dhaka Tribune December 18, 2020 08:03 UTC